2. Expanding tropical disease product priority review voucher program to encourage treatments for coronavirus Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended— ⋯ (1) by redesignating subparagraph (S) as subparagraph (T); and ⋯ (2) by inserting after subparagraph (R) the following: ⋯ “(S) The 2019 novel coronavirus (COVID–19).”